newsfilter
← Latest News
Business Wire·

Axonics Reports Second Quarter 2023 Financial Results

Generated quarterly revenue of $92.9 million, an increase of 35% year over year Fiscal year 2023 revenue guidance increased to $358 million Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is